Advertisement

Related Videos

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Opening Session Panel Discussion

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement




Dec
05
Today In Oncology
Reducing the Barriers to Receiving CAR T-Cell Therapy for Patients With Hematologic Malignancies
Study Identifies Rectal Bleeding as Key Predictor of Early-Onset Colorectal Cancer
Nivolumab and Ipilimumab in Advanced dMMR/MSI-H Noncolorectal Cancers
T-DXd Plus Pertuzumab in HER2-Positive Advanced or Metastatic Breast Cancer
AACR Pediatric Cancer Progress Report 2025
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo